Business
Currency:USD
2025/Q1
Stock NameRevenueRatio
FILSPARI55.88M68.37%
Tiopronin products19.98M24.45%
License and collaboration revenue5.87M7.18%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States233.18M100.00%